Prescription GLP-1 medications like semaglutide and tirzepatide demonstrated 1422% body weight loss in clinical trials
Over a typical thinning area of 50100 cm, this could mean 7502,000 additional hairs
P., Koroleva, A., Lingvay, I., ONeil, P
However, the injectable form (Wegovy) is currently the only one approved for weight loss, and it is taken once a week, while the oral version for diabetes is taken daily
Researchers in life sciences must follow protocols consistent with lab research standards
We have only limited experience in filing the applications necessary to gain regulatory approvals and expect to rely on consultants and third-party contract research organizations, or CROs, with expertise in this area to assist us in this process